Senior insider sale
Senior VP, R&D at REPLIGEN CORP — senior position signals high conviction
$681.3K
3.52K shares
What this filing means
KURIYEL RALF plans to sell 3.52K shares of REPLIGEN CORP valued at approximately $681.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/11/2024ACC: 0001969223-24-000251
3.52K
Shares to sell
$681.3K
Approx. market value
3.52K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months4
Stock Option Exercise
Cash
3/11/2024
1.27KRSU Vesting Event
NA
2/24/2023
468.00RSU Vesting Event
NA
5/13/2022
888.00RSU Vesting Event
na
5/13/2021
890.00Total acquired3.52K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/11/2024 | Stock Option Exercise Cash | 1.27K | — |
2/24/2023 | RSU Vesting Event NA | 468.00 | — |
5/13/2022 | RSU Vesting Event NA | 888.00 | — |
5/13/2021 | RSU Vesting Event na | 890.00 | — |
| Total | 3.52K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
3.52K
Market value
$681.3K
3/11/2024
Total
Units
3.52K
Value
$681.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/11/2024 | 3.52K | $681.3K | NASDAQ | Planned |
| Total | 3.52K | $681.3K | ||